Treatment of gynecological infectious and inflammatory diseases: Current trends and recent advances
Meditsinskiy sovet = Medical Council · 11.05.2026 · (4) · 61-69
DOI: 10.21518/ms2026-131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Meditsinskiy sovet = Medical Council, online erschienen am 11.05.2026. Verfasst von A. Z. Khashukoeva und 4 weiteren Autor:innen. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Pelvic inflammatory disease (PID) can be defined as one of the primary and complex issues of vital importance in modern gynecology. Vulvovaginal infections can act as a provocative factor for both PID with its potential complications in the future, and those of the concomitant course. This descriptive review evaluates data on the efficacy of Miramistin in the treatment of pelvic inflammatory diseases. The analysis of the outcomes of comprehensive therapy of PID using antiseptic agent benzyldimethyl[3-(myristoylamino)propyl]ammonium chloride monohydrate (Miramistin®) in the dosage form of vaginal suppositories is provided. Topical combination therapy regimens for infectious and inflammatory GT diseases including Miramistin® vaginal suppositories has demonstrated high clinical efficacy in women with a wide range of PID associated with a wide variety of cervicovaginal flora. This article aims to identify and characterize current trends within PID therapy. The research into the review topic to prepare and write the paper involved various search queries to select publications subject to analysis. A literature review was conducted using English-language databases MEDLINE and PubMed with the keywords: sexually transmitted infections, cervical-vaginal infections, mixed infections, pelvic inflammatory diseases, PID, antiseptic, benzyldimethyl-myristoilamino-propylammonium, and miramistin. From articles retrieved, clinical trials with large sample sizes, systematic reviews, and meta-analyses were prioritized, yielding 47 articles on the subject matter to prepare the paper, and 41 articles for screening (cited reference lists). These reference links included important data: results of RCTs, clinical and cohort studies, as well as the theoretical background to substantiate the efficacy of this medication.
Zitieren
APA
Khashukoeva, A. Z., Markova, E. A., Khashukoeva, Z. Z., Gogutlova, D. Z., & Kuznetsov, D. A. (2026). Treatment of gynecological infectious and inflammatory diseases: Current trends and recent advances. Meditsinskiy sovet = Medical Council, 61-69. https://doi.org/10.21518/ms2026-131
Vancouver
Khashukoeva AZ, Markova EA, Khashukoeva ZZ, Gogutlova DZ, Kuznetsov DA. Treatment of gynecological infectious and inflammatory diseases: Current trends and recent advances. Meditsinskiy sovet = Medical Council. 2026:61-69. doi:10.21518/ms2026-131
BibTeX
@article{Khashukoeva2026,
author = {Khashukoeva, A. Z. and Markova, E. A. and Khashukoeva, Z. Z. and Gogutlova, D. Z. and Kuznetsov, D. A.},
title = {Treatment of gynecological infectious and inflammatory diseases: Current trends and recent advances},
journal = {Meditsinskiy sovet = Medical Council},
year = {2026},
number = {4},
pages = {61--69},
doi = {10.21518/ms2026-131}
}
EUVIMED